ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $64,824 | -35.1% | 281,845 | 0.0% | 0.00% | – |
| Q1 2023 | $99,886 | -44.8% | 281,845 | -50.0% | 0.00% | – |
| Q4 2022 | $180,888 | -12.2% | 563,690 | +100.0% | 0.00% | – |
| Q3 2022 | $206,000 | -29.9% | 281,845 | -13.8% | 0.00% | – |
| Q2 2022 | $294,000 | -85.5% | 327,145 | -75.9% | 0.00% | – |
| Q1 2022 | $2,023,000 | -32.7% | 1,357,513 | -2.0% | 0.00% | – |
| Q4 2021 | $3,006,000 | -39.8% | 1,385,461 | -1.3% | 0.00% | – |
| Q3 2021 | $4,997,000 | -31.1% | 1,403,564 | +11.1% | 0.00% | – |
| Q2 2021 | $7,251,000 | +25.9% | 1,263,199 | +13.9% | 0.00% | – |
| Q1 2021 | $5,758,000 | +158.3% | 1,109,356 | +19.0% | 0.00% | – |
| Q4 2020 | $2,229,000 | +134.1% | 932,480 | +36.2% | 0.00% | – |
| Q3 2020 | $952,000 | -20.2% | 684,637 | +9.6% | 0.00% | – |
| Q2 2020 | $1,193,000 | +13.5% | 624,652 | +45.7% | 0.00% | – |
| Q1 2020 | $1,051,000 | +7.4% | 428,858 | -1.5% | 0.00% | – |
| Q4 2019 | $979,000 | +10.7% | 435,208 | +3.4% | 0.00% | – |
| Q3 2019 | $884,000 | +0.8% | 420,833 | +19.4% | 0.00% | – |
| Q2 2019 | $877,000 | +2148.7% | 352,320 | +1834.7% | 0.00% | – |
| Q1 2018 | $39,000 | -46.6% | 18,211 | +14.5% | 0.00% | – |
| Q4 2017 | $73,000 | -55.2% | 15,899 | -56.0% | 0.00% | – |
| Q1 2016 | $163,000 | – | 36,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |